These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 22290244)
1. Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells. Yao K; Youn H; Gao X; Huang B; Zhou F; Li B; Han H Prostate; 2012 Sep; 72(13):1423-30. PubMed ID: 22290244 [TBL] [Abstract][Full Text] [Related]
2. [Both CK2 catalytic subunits involves in androgen receptor signaling in prostate cancer cells]. Yao K; Gao XY; Huang BJ; Li ZS; Zhou FJ; Li BY; Han H Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3360-3. PubMed ID: 24418032 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of protein kinase CK2 leads to a modulation of androgen receptor dependent transcription in prostate cancer cells. Götz C; Bachmann C; Montenarh M Prostate; 2007 Feb; 67(2):125-34. PubMed ID: 17044081 [TBL] [Abstract][Full Text] [Related]
4. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539 [TBL] [Abstract][Full Text] [Related]
5. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation. Seaton A; Scullin P; Maxwell PJ; Wilson C; Pettigrew J; Gallagher R; O'Sullivan JM; Johnston PG; Waugh DJ Carcinogenesis; 2008 Jun; 29(6):1148-56. PubMed ID: 18487223 [TBL] [Abstract][Full Text] [Related]
7. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2. Schneider CC; Hessenauer A; Montenarh M; Götz C Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628 [TBL] [Abstract][Full Text] [Related]
8. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890 [TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
10. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor. Trtková K; Pašková L; Matiješčuková N; Kolář Z Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266 [TBL] [Abstract][Full Text] [Related]
11. Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells. Shiota M; Yokomizo A; Kashiwagi E; Takeuchi A; Fujimoto N; Uchiumi T; Naito S Free Radic Biol Med; 2011 Jul; 51(1):78-87. PubMed ID: 21539911 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Chiu FL; Lin JK Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
14. Etoposide induces growth arrest and disrupts androgen receptor signaling in prostate cancer cells. Liu S; Yamauchi H Oncol Rep; 2010 Jan; 23(1):165-70. PubMed ID: 19956877 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
16. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977 [TBL] [Abstract][Full Text] [Related]
17. Camptothecin disrupts androgen receptor signaling and suppresses prostate cancer cell growth. Liu S; Yuan Y; Okumura Y; Shinkai N; Yamauchi H Biochem Biophys Res Commun; 2010 Apr; 394(2):297-302. PubMed ID: 20206136 [TBL] [Abstract][Full Text] [Related]
18. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth. Mashima T; Okabe S; Seimiya H Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811 [TBL] [Abstract][Full Text] [Related]
20. Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancer. Narayanan R; Yepuru M; Szafran AT; Szwarc M; Bohl CE; Young NL; Miller DD; Mancini MA; Dalton JT Cancer Res; 2010 Jan; 70(2):842-51. PubMed ID: 20068182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]